Pfizer’s experimental COVID-19 antiviral can cut the risk of ending up in the hospital or dying by 89%, and this means that Americans may soon have a choice in COVID-19 pills that they can take at home.

The news sent shares of Pfizer PFE soaring 8.2% in trading on Friday, capping off a week in which the company reported better-than-expected sales of its COVID-19 vaccine and shared that its oral COVID-19 pill had compelling results in a clinical trial.

“As…

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:Latest News